(MSTR) MicroStrategy - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5949724083
Stock: Bitcoin, Analytics Software, Data Governance
Total Rating 10
Risk 66
Buy Signal -1.20
| Risk 5d forecast | |
|---|---|
| Volatility | 92.0% |
| Relative Tail Risk | -6.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.59 |
| Alpha | -96.07 |
| Character TTM | |
|---|---|
| Beta | 2.395 |
| Beta Downside | 3.365 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.42% |
| CAGR/Max DD | 1.10 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: MSTR MicroStrategy March 04, 2026
MicroStrategy Inc. (MSTR) operates as a bitcoin treasury company globally, providing investors with exposure to bitcoin through equity and fixed-income securities. This business model is unique as it directly ties corporate value to a volatile digital asset.
The company also develops and sells AI-powered enterprise analytics software. This positions MSTR in the competitive enterprise software sector, which focuses on delivering tools for data analysis and business intelligence. Its products, Strategy One and Strategy Mosaic, aim to provide accessible insights and data governance.
MicroStrategy Inc. was founded in 1989 and is headquartered in Tysons Corner, Virginia. For a deeper analysis of the companys financial performance and market position, consider exploring ValueRay.
Headlines to watch out for
- Bitcoin price volatility impacts MSTRs treasury value
- Enterprise analytics software sales drive revenue
- Regulatory changes for cryptocurrency holdings pose risk
- Competition in AI-powered analytics market affects growth
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income: -4.03b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.32 > 0.02 and ΔFCF/TA 54.04 > 1.0 |
| NWC/Revenue: 441.6% < 20% (prev -22.24%; Δ 463.9% < -1%) |
| CFO/TA -0.00 > 3% & CFO -67.2m > Net Income -4.03b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 5.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (294.0m) vs 12m ago 32.67% < -2% |
| Gross Margin: 68.69% > 18% (prev 0.72%; Δ 6797 % > 0.5%) |
| Asset Turnover: 1.09% > 50% (prev 1.79%; Δ -0.70% > 0%) |
| Interest Coverage Ratio: -84.06 > 6 (EBITDA TTM -5.44b / Interest Expense TTM 65.0m) |
Altman Z'' 0.35
| A: 0.03 (Total Current Assets 2.56b - Total Current Liabilities 456.5m) / Total Assets 61.64b |
| B: 0.10 (Retained Earnings 6.32b / Total Assets 61.64b) |
| C: -0.12 (EBIT TTM -5.46b / Avg Total Assets 43.74b) |
| D: 0.60 (Book Value of Equity 6.32b / Total Liabilities 10.60b) |
| Altman-Z'' Score: 0.35 = B |
Beneish M -2.96
| DSRI: 1.10 (Receivables 205.7m/181.2m, Revenue 477.2m/463.5m) |
| GMI: 1.05 (GM 68.69% / 72.06%) |
| AQI: 0.97 (AQ_t 0.96 / AQ_t-1 0.99) |
| SGI: 1.03 (Revenue 477.2m / 463.5m) |
| TATA: -0.06 (NI -4.03b - CFO -67.2m) / TA 61.64b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of MSTR shares?
As of March 10, 2026, the stock is trading at USD 138.95 with a total of 20,367,234 shares traded.
Over the past week, the price has changed by +0.94%, over one month by +0.37%, over three months by -26.48% and over the past year by -41.93%.
Over the past week, the price has changed by +0.94%, over one month by +0.37%, over three months by -26.48% and over the past year by -41.93%.
Is MSTR a buy, sell or hold?
MicroStrategy has received a consensus analysts rating of 4.31.
Therefore, it is recommended to buy MSTR.
- StrongBuy: 7
- Buy: 5
- Hold: 0
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the MSTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 394.4 | 183.8% |
| Analysts Target Price | 394.4 | 183.8% |
MSTR Fundamental Data Overview March 07, 2026
P/E Forward = 1.1055
P/S = 97.7761
P/B = 1.1077
P/EG = 2.8502
Revenue TTM = 477.2m USD
EBIT TTM = -5.46b USD
EBITDA TTM = -5.44b USD
Long Term Debt = 8.16b USD (from longTermDebt, last quarter)
Short Term Debt = 31.3m USD (from shortTermDebt, last quarter)
Debt = 8.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.98b USD (from netDebt column, last quarter)
Enterprise Value = 52.64b USD (46.66b + Debt 8.28b - CCE 2.30b)
Interest Coverage Ratio = -84.06 (Ebit TTM -5.46b / Interest Expense TTM 65.0m)
EV/FCF = -2.70x (Enterprise Value 52.64b / FCF TTM -19.50b)
FCF Yield = -37.03% (FCF TTM -19.50b / Enterprise Value 52.64b)
FCF Margin = -4085 % (FCF TTM -19.50b / Revenue TTM 477.2m)
Net Margin = -844.8% (Net Income TTM -4.03b / Revenue TTM 477.2m)
Gross Margin = 68.69% ((Revenue TTM 477.2m - Cost of Revenue TTM 149.4m) / Revenue TTM)
Gross Margin QoQ = 66.11% (prev 70.46%)
Tobins Q-Ratio = 0.85 (Enterprise Value 52.64b / Total Assets 61.64b)
Interest Expense / Debt = 0.13% (Interest Expense 11.1m / Debt 8.28b)
Taxrate = 21.0% (US default 21%)
NOPAT = -4.31b (EBIT -5.46b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 5.62 (Total Current Assets 2.56b / Total Current Liabilities 456.5m)
Debt / Equity = 0.16 (Debt 8.28b / totalStockholderEquity, last quarter 51.04b)
Debt / EBITDA = -1.10 (negative EBITDA) (Net Debt 5.98b / EBITDA -5.44b)
Debt / FCF = -0.31 (negative FCF - burning cash) (Net Debt 5.98b / FCF TTM -19.50b)
Total Stockholder Equity = 48.26b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.22% (Net Income -4.03b / Total Assets 61.64b)
RoE = -8.35% (Net Income TTM -4.03b / Total Stockholder Equity 48.26b)
RoCE = -9.68% (EBIT -5.46b / Capital Employed (Equity 48.26b + L.T.Debt 8.16b))
RoIC = -8.26% (negative operating profit) (NOPAT -4.31b / Invested Capital 52.20b)
WACC = 12.53% (E(46.66b)/V(54.94b) * Re(14.74%) + D(8.28b)/V(54.94b) * Rd(0.13%) * (1-Tc(0.21)))
Discount Rate = 14.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 26.49%
[DCF] Fair Price = unknown (Cash Flow -19.50b)
EPS Correlation: 21.80 | EPS CAGR: -12.16% | SUE: -3.96 | # QB: 0
Revenue Correlation: -30.01 | Revenue CAGR: 0.82% | SUE: 0.25 | # QB: 0
EPS next Quarter (2026-06-30): EPS=24.40 | Chg7d=+0.000 | Chg30d=+13.243 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=72.17 | Chg7d=+0.000 | Chg30d=+10.111 | Revisions Net=+0 | Growth EPS=+573.9% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=43.12 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=-40.2% | Growth Revenue=-2.3%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Current Year)
P/S = 97.7761
P/B = 1.1077
P/EG = 2.8502
Revenue TTM = 477.2m USD
EBIT TTM = -5.46b USD
EBITDA TTM = -5.44b USD
Long Term Debt = 8.16b USD (from longTermDebt, last quarter)
Short Term Debt = 31.3m USD (from shortTermDebt, last quarter)
Debt = 8.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.98b USD (from netDebt column, last quarter)
Enterprise Value = 52.64b USD (46.66b + Debt 8.28b - CCE 2.30b)
Interest Coverage Ratio = -84.06 (Ebit TTM -5.46b / Interest Expense TTM 65.0m)
EV/FCF = -2.70x (Enterprise Value 52.64b / FCF TTM -19.50b)
FCF Yield = -37.03% (FCF TTM -19.50b / Enterprise Value 52.64b)
FCF Margin = -4085 % (FCF TTM -19.50b / Revenue TTM 477.2m)
Net Margin = -844.8% (Net Income TTM -4.03b / Revenue TTM 477.2m)
Gross Margin = 68.69% ((Revenue TTM 477.2m - Cost of Revenue TTM 149.4m) / Revenue TTM)
Gross Margin QoQ = 66.11% (prev 70.46%)
Tobins Q-Ratio = 0.85 (Enterprise Value 52.64b / Total Assets 61.64b)
Interest Expense / Debt = 0.13% (Interest Expense 11.1m / Debt 8.28b)
Taxrate = 21.0% (US default 21%)
NOPAT = -4.31b (EBIT -5.46b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 5.62 (Total Current Assets 2.56b / Total Current Liabilities 456.5m)
Debt / Equity = 0.16 (Debt 8.28b / totalStockholderEquity, last quarter 51.04b)
Debt / EBITDA = -1.10 (negative EBITDA) (Net Debt 5.98b / EBITDA -5.44b)
Debt / FCF = -0.31 (negative FCF - burning cash) (Net Debt 5.98b / FCF TTM -19.50b)
Total Stockholder Equity = 48.26b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.22% (Net Income -4.03b / Total Assets 61.64b)
RoE = -8.35% (Net Income TTM -4.03b / Total Stockholder Equity 48.26b)
RoCE = -9.68% (EBIT -5.46b / Capital Employed (Equity 48.26b + L.T.Debt 8.16b))
RoIC = -8.26% (negative operating profit) (NOPAT -4.31b / Invested Capital 52.20b)
WACC = 12.53% (E(46.66b)/V(54.94b) * Re(14.74%) + D(8.28b)/V(54.94b) * Rd(0.13%) * (1-Tc(0.21)))
Discount Rate = 14.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 26.49%
[DCF] Fair Price = unknown (Cash Flow -19.50b)
EPS Correlation: 21.80 | EPS CAGR: -12.16% | SUE: -3.96 | # QB: 0
Revenue Correlation: -30.01 | Revenue CAGR: 0.82% | SUE: 0.25 | # QB: 0
EPS next Quarter (2026-06-30): EPS=24.40 | Chg7d=+0.000 | Chg30d=+13.243 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=72.17 | Chg7d=+0.000 | Chg30d=+10.111 | Revisions Net=+0 | Growth EPS=+573.9% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=43.12 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=-40.2% | Growth Revenue=-2.3%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Current Year)